98,033 Shares in The Clorox Company (NYSE:CLX) Bought by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 98,033 shares of the company's stock, valued at approximately $15,922,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.08% of Clorox at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Redwood Park Advisors LLC purchased a new position in shares of Clorox during the fourth quarter worth approximately $26,000. Millstone Evans Group LLC bought a new stake in shares of Clorox in the fourth quarter valued at about $31,000. Asset Planning Inc bought a new stake in shares of Clorox in the fourth quarter valued at about $32,000. GKV Capital Management Co. Inc. purchased a new stake in Clorox in the fourth quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd bought a new position in Clorox during the 4th quarter worth about $33,000. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

NYSE CLX traded up $0.77 during trading hours on Friday, hitting $131.76. 2,492,592 shares of the company's stock traded hands, compared to its average volume of 1,341,934. The Clorox Company has a 52-week low of $129.19 and a 52-week high of $171.37. The company has a market capitalization of $16.24 billion, a PE ratio of 36.00, a PEG ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm's 50-day moving average is $138.30 and its 200-day moving average is $151.24.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm's revenue was down 8.0% compared to the same quarter last year. During the same period last year, the business earned $1.71 earnings per share. Equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Insider Activity

In related news, Director Pierre R. Breber acquired 4,000 shares of the firm's stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the acquisition, the director now owns 4,000 shares in the company, valued at $546,280. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.57% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Barclays cut their price objective on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a report on Wednesday, May 7th. Wells Fargo & Company lowered their price objective on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Morgan Stanley lowered their price objective on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. DA Davidson decreased their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $151.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.